Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights

Go back to Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
(NASDAQ: CBIO) Delayed: 17.57 -0.12 (0.68%)
Previous Close $17.69    52 Week High $4.57 
Open $17.90    52 Week Low $0.62 
Day High $18.85    P/E N/A 
Day Low $17.49    EPS $0.00 
Volume 307,152